SemiAlloGen is a privately held, Charleston-based biotech company that has developed a unique, proprietary platform technology for the production of vaccines and therapeutics for cancer and neurological degenerative diseases. Today, they are testing their product on animals at MUSC and hope to eventually market a vaccine for diseases like cancer and Alzheimer's. Recently, SemiAlloGen was featured in the Charleston Business Journal.  A link to this article can be found at: http://www.scbiznews.com/content/view/11539/1/ SemiAlloGen is currently looking for funding.

 

To learn more about SemiAlloGen, please go directly to their website at: http://semiallogen.awardspace.com